nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—PSMB10—cerebellum—meningioma	0.00824	0.104	CbGeAlD
Carfilzomib—PSMB10—brain—meningioma	0.00669	0.0843	CbGeAlD
Carfilzomib—PSMB5—medulla oblongata—meningioma	0.00663	0.0836	CbGeAlD
Carfilzomib—PSMB5—spinal cord—meningioma	0.00591	0.0745	CbGeAlD
Carfilzomib—PSMB1—medulla oblongata—meningioma	0.0058	0.073	CbGeAlD
Carfilzomib—PSMB2—medulla oblongata—meningioma	0.00566	0.0713	CbGeAlD
Carfilzomib—PSMB1—spinal cord—meningioma	0.00517	0.0651	CbGeAlD
Carfilzomib—PSMB2—spinal cord—meningioma	0.00504	0.0635	CbGeAlD
Carfilzomib—PSMB5—cerebellum—meningioma	0.00469	0.0591	CbGeAlD
Carfilzomib—PSMB8—brain—meningioma	0.00431	0.0543	CbGeAlD
Carfilzomib—PSMB1—cerebellum—meningioma	0.0041	0.0516	CbGeAlD
Carfilzomib—PSMB2—cerebellum—meningioma	0.004	0.0504	CbGeAlD
Carfilzomib—PSMB5—brain—meningioma	0.00381	0.048	CbGeAlD
Carfilzomib—PSMB1—brain—meningioma	0.00333	0.0419	CbGeAlD
Carfilzomib—PSMB2—brain—meningioma	0.00325	0.0409	CbGeAlD
Carfilzomib—PSMB2—B Cell Activation—PTEN—meningioma	0.00166	0.0018	CbGpPWpGaD
Carfilzomib—PSMB8—B Cell Activation—PTEN—meningioma	0.00163	0.00177	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD34—meningioma	0.0016	0.00174	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD34—meningioma	0.0016	0.00174	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD34—meningioma	0.0016	0.00174	CbGpPWpGaD
Carfilzomib—PSMB10—Gene Expression—PGR—meningioma	0.00159	0.00173	CbGpPWpGaD
Carfilzomib—PSMB9—Gene Expression—PGR—meningioma	0.00158	0.00172	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD34—meningioma	0.00158	0.00171	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—meningioma	0.00155	0.00168	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—PDGFB—meningioma	0.00154	0.00167	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—PDGFB—meningioma	0.00153	0.00167	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CTSL—meningioma	0.00152	0.00166	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CTSL—meningioma	0.00152	0.00166	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CTSL—meningioma	0.00152	0.00166	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—TSHB—meningioma	0.00152	0.00165	CbGpPWpGaD
Carfilzomib—PSMB10—Apoptosis—AKT1—meningioma	0.00151	0.00164	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—TSHB—meningioma	0.00151	0.00164	CbGpPWpGaD
Carfilzomib—PSMB9—Apoptosis—AKT1—meningioma	0.00151	0.00164	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CTSL—meningioma	0.0015	0.00163	CbGpPWpGaD
Carfilzomib—PSMB10—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	0.00143	0.00155	CbGpPWpGaD
Carfilzomib—PSMB9—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	0.00142	0.00154	CbGpPWpGaD
Carfilzomib—PSMB5—Apoptosis—TP53—meningioma	0.00136	0.00147	CbGpPWpGaD
Carfilzomib—PSMB1—Apoptosis—TP53—meningioma	0.00136	0.00147	CbGpPWpGaD
Carfilzomib—PSMB2—Apoptosis—TP53—meningioma	0.00136	0.00147	CbGpPWpGaD
Carfilzomib—PSMB8—Apoptosis—TP53—meningioma	0.00134	0.00145	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CST3—meningioma	0.0013	0.00141	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CST3—meningioma	0.0013	0.00141	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CST3—meningioma	0.0013	0.00141	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CST3—meningioma	0.00128	0.00139	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TSHB—meningioma	0.00127	0.00138	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TSHB—meningioma	0.00126	0.00137	CbGpPWpGaD
Carfilzomib—PSMB10—B Cell Activation—AKT1—meningioma	0.00126	0.00137	CbGpPWpGaD
Carfilzomib—PSMB9—B Cell Activation—AKT1—meningioma	0.00125	0.00136	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—PGR—meningioma	0.0012	0.00131	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—PGR—meningioma	0.0012	0.00131	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—PGR—meningioma	0.0012	0.00131	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—PGR—meningioma	0.00119	0.00129	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—PDGFB—meningioma	0.00117	0.00127	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—PDGFB—meningioma	0.00117	0.00127	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—PDGFB—meningioma	0.00117	0.00127	CbGpPWpGaD
Carfilzomib—PSMB10—TCF dependent signaling in response to WNT—AKT1—meningioma	0.00115	0.00125	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—PDGFB—meningioma	0.00115	0.00125	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—TSHB—meningioma	0.00115	0.00125	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—TSHB—meningioma	0.00115	0.00125	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—TSHB—meningioma	0.00115	0.00125	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism of mRNA—AKT1—meningioma	0.00115	0.00125	CbGpPWpGaD
Carfilzomib—PSMB5—Apoptosis—AKT1—meningioma	0.00115	0.00125	CbGpPWpGaD
Carfilzomib—PSMB2—Apoptosis—AKT1—meningioma	0.00115	0.00125	CbGpPWpGaD
Carfilzomib—PSMB1—Apoptosis—AKT1—meningioma	0.00115	0.00125	CbGpPWpGaD
Carfilzomib—PSMB9—TCF dependent signaling in response to WNT—AKT1—meningioma	0.00115	0.00124	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism of mRNA—AKT1—meningioma	0.00114	0.00124	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—TSHB—meningioma	0.00113	0.00123	CbGpPWpGaD
Carfilzomib—PSMB8—Apoptosis—AKT1—meningioma	0.00113	0.00123	CbGpPWpGaD
Carfilzomib—PSMB10—RNF mutants show enhanced WNT signaling and proliferation—AKT1—meningioma	0.00111	0.00121	CbGpPWpGaD
Carfilzomib—PSMB9—RNF mutants show enhanced WNT signaling and proliferation—AKT1—meningioma	0.00111	0.00121	CbGpPWpGaD
Carfilzomib—PSMB5—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	0.00108	0.00117	CbGpPWpGaD
Carfilzomib—PSMB1—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	0.00108	0.00117	CbGpPWpGaD
Carfilzomib—PSMB2—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	0.00108	0.00117	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—SMO—meningioma	0.00108	0.00117	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—SMO—meningioma	0.00107	0.00117	CbGpPWpGaD
Carfilzomib—PSMB8—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	0.00106	0.00116	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling by WNT in cancer—AKT1—meningioma	0.00104	0.00112	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—PGR—meningioma	0.00103	0.00112	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—ERBB2—meningioma	0.00103	0.00112	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling by WNT in cancer—AKT1—meningioma	0.00103	0.00112	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—PGR—meningioma	0.00103	0.00112	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—ERBB2—meningioma	0.00103	0.00112	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—HES1—meningioma	0.00101	0.0011	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—HES1—meningioma	0.001	0.00109	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism of RNA—AKT1—meningioma	0.000982	0.00107	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism of RNA—AKT1—meningioma	0.000977	0.00106	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TSHB—meningioma	0.000961	0.00104	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TSHB—meningioma	0.000961	0.00104	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TSHB—meningioma	0.000961	0.00104	CbGpPWpGaD
Carfilzomib—PSMB1—B Cell Activation—AKT1—meningioma	0.000954	0.00104	CbGpPWpGaD
Carfilzomib—PSMB5—B Cell Activation—AKT1—meningioma	0.000954	0.00104	CbGpPWpGaD
Carfilzomib—PSMB2—B Cell Activation—AKT1—meningioma	0.000954	0.00104	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TSHB—meningioma	0.000947	0.00103	CbGpPWpGaD
Carfilzomib—PSMB8—B Cell Activation—AKT1—meningioma	0.000941	0.00102	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—PDGFB—meningioma	0.000935	0.00102	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—PDGFB—meningioma	0.00093	0.00101	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—PTEN—meningioma	0.000881	0.000957	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—PTEN—meningioma	0.000876	0.000952	CbGpPWpGaD
Carfilzomib—PSMB5—TCF dependent signaling in response to WNT—AKT1—meningioma	0.000873	0.000948	CbGpPWpGaD
Carfilzomib—PSMB1—TCF dependent signaling in response to WNT—AKT1—meningioma	0.000873	0.000948	CbGpPWpGaD
Carfilzomib—PSMB2—TCF dependent signaling in response to WNT—AKT1—meningioma	0.000873	0.000948	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism of mRNA—AKT1—meningioma	0.000869	0.000944	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism of mRNA—AKT1—meningioma	0.000869	0.000944	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism of mRNA—AKT1—meningioma	0.000869	0.000944	CbGpPWpGaD
Carfilzomib—ABCB1—medulla oblongata—meningioma	0.000864	0.0109	CbGeAlD
Carfilzomib—PSMB10—Disease—PDGFB—meningioma	0.000863	0.000937	CbGpPWpGaD
Carfilzomib—PSMB8—TCF dependent signaling in response to WNT—AKT1—meningioma	0.00086	0.000934	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—PDGFB—meningioma	0.000859	0.000933	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism of mRNA—AKT1—meningioma	0.000857	0.000931	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling by Wnt—AKT1—meningioma	0.000853	0.000927	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling by Wnt—AKT1—meningioma	0.000849	0.000923	CbGpPWpGaD
Carfilzomib—PSMB5—RNF mutants show enhanced WNT signaling and proliferation—AKT1—meningioma	0.000845	0.000918	CbGpPWpGaD
Carfilzomib—PSMB1—RNF mutants show enhanced WNT signaling and proliferation—AKT1—meningioma	0.000845	0.000918	CbGpPWpGaD
Carfilzomib—PSMB2—RNF mutants show enhanced WNT signaling and proliferation—AKT1—meningioma	0.000845	0.000918	CbGpPWpGaD
Carfilzomib—PSMB8—RNF mutants show enhanced WNT signaling and proliferation—AKT1—meningioma	0.000833	0.000905	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—SMO—meningioma	0.000817	0.000887	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—SMO—meningioma	0.000817	0.000887	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—SMO—meningioma	0.000817	0.000887	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—SMO—meningioma	0.000805	0.000875	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling by WNT in cancer—AKT1—meningioma	0.000785	0.000852	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling by WNT in cancer—AKT1—meningioma	0.000785	0.000852	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling by WNT in cancer—AKT1—meningioma	0.000785	0.000852	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PGR—meningioma	0.000783	0.000851	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PGR—meningioma	0.000783	0.000851	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PGR—meningioma	0.000783	0.000851	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—ERBB2—meningioma	0.000783	0.00085	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—ERBB2—meningioma	0.000783	0.00085	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—ERBB2—meningioma	0.000783	0.00085	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling by WNT in cancer—AKT1—meningioma	0.000773	0.00084	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PGR—meningioma	0.000772	0.000839	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—ERBB2—meningioma	0.000772	0.000838	CbGpPWpGaD
Carfilzomib—ABCB1—spinal cord—meningioma	0.00077	0.00971	CbGeAlD
Carfilzomib—PSMB1—Disease—HES1—meningioma	0.000765	0.00083	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—HES1—meningioma	0.000765	0.00083	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—HES1—meningioma	0.000765	0.00083	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—HES1—meningioma	0.000754	0.000819	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism of RNA—AKT1—meningioma	0.000744	0.000808	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism of RNA—AKT1—meningioma	0.000744	0.000808	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism of RNA—AKT1—meningioma	0.000744	0.000808	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism of RNA—AKT1—meningioma	0.000734	0.000797	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—PDGFB—meningioma	0.000708	0.000769	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—PDGFB—meningioma	0.000708	0.000769	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—PDGFB—meningioma	0.000708	0.000769	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—HES1—meningioma	0.000706	0.000767	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—HES1—meningioma	0.000703	0.000764	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—PDGFB—meningioma	0.000698	0.000758	CbGpPWpGaD
Carfilzomib—ABCB1—HIF-1-alpha transcription factor network—AKT1—meningioma	0.000668	0.000725	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—PTEN—meningioma	0.000667	0.000725	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—PTEN—meningioma	0.000667	0.000725	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—PTEN—meningioma	0.000667	0.000725	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—PTEN—meningioma	0.000658	0.000715	CbGpPWpGaD
Carfilzomib—PSMB10—Cell Cycle—TP53—meningioma	0.000656	0.000713	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—PDGFB—meningioma	0.000654	0.00071	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—PDGFB—meningioma	0.000654	0.00071	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—PDGFB—meningioma	0.000654	0.00071	CbGpPWpGaD
Carfilzomib—PSMB9—Cell Cycle—TP53—meningioma	0.000653	0.000709	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling by Wnt—AKT1—meningioma	0.000647	0.000702	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling by Wnt—AKT1—meningioma	0.000647	0.000702	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling by Wnt—AKT1—meningioma	0.000647	0.000702	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—PDGFB—meningioma	0.000645	0.0007	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling by Wnt—AKT1—meningioma	0.000638	0.000693	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—ERBB2—meningioma	0.000626	0.00068	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—ERBB2—meningioma	0.000623	0.000677	CbGpPWpGaD
Carfilzomib—ABCB1—cerebellum—meningioma	0.000611	0.0077	CbGeAlD
Carfilzomib—PSMB10—Signaling Pathways—PDGFB—meningioma	0.000604	0.000656	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—PDGFB—meningioma	0.000601	0.000653	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.000581	0.000631	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—ERBB2—meningioma	0.000578	0.000628	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—ERBB2—meningioma	0.000576	0.000625	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—HES1—meningioma	0.000535	0.000582	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—HES1—meningioma	0.000535	0.000582	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—HES1—meningioma	0.000535	0.000582	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—PTEN—meningioma	0.000534	0.00058	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—PTEN—meningioma	0.000532	0.000577	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—HES1—meningioma	0.000528	0.000573	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALAD—meningioma	0.000525	0.00057	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—AKT1—meningioma	0.000508	0.000551	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—AKT1—meningioma	0.000505	0.000549	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle—TP53—meningioma	0.000497	0.00054	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle—TP53—meningioma	0.000497	0.00054	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle—TP53—meningioma	0.000497	0.00054	CbGpPWpGaD
Carfilzomib—ABCB1—brain—meningioma	0.000496	0.00625	CbGeAlD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.000495	0.000538	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—PTEN—meningioma	0.000493	0.000536	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—PTEN—meningioma	0.000491	0.000533	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle—TP53—meningioma	0.00049	0.000532	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—ERBB2—meningioma	0.000475	0.000516	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—ERBB2—meningioma	0.000475	0.000516	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—ERBB2—meningioma	0.000475	0.000516	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—ERBB2—meningioma	0.000468	0.000508	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PDGFB—meningioma	0.000458	0.000497	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PDGFB—meningioma	0.000458	0.000497	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PDGFB—meningioma	0.000458	0.000497	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PDGFB—meningioma	0.000451	0.00049	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—ERBB2—meningioma	0.000438	0.000476	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—ERBB2—meningioma	0.000438	0.000476	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—ERBB2—meningioma	0.000438	0.000476	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—ERBB2—meningioma	0.000432	0.000469	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—PTEN—meningioma	0.000413	0.000449	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—PTEN—meningioma	0.000411	0.000446	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—ERBB2—meningioma	0.000405	0.00044	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—PTEN—meningioma	0.000405	0.00044	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—PTEN—meningioma	0.000405	0.00044	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—PTEN—meningioma	0.000405	0.00044	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—ERBB2—meningioma	0.000403	0.000438	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—PTEN—meningioma	0.000399	0.000433	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—AKT1—meningioma	0.000385	0.000418	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—AKT1—meningioma	0.000385	0.000418	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—AKT1—meningioma	0.000385	0.000418	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—AKT1—meningioma	0.000379	0.000412	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—PTEN—meningioma	0.000374	0.000406	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—PTEN—meningioma	0.000374	0.000406	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—PTEN—meningioma	0.000374	0.000406	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—PTEN—meningioma	0.000368	0.0004	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—PTEN—meningioma	0.000345	0.000375	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—PTEN—meningioma	0.000344	0.000373	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—TSHB—meningioma	0.000338	0.000367	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.000338	0.000367	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PTEN—meningioma	0.000313	0.00034	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PTEN—meningioma	0.000313	0.00034	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PTEN—meningioma	0.000313	0.00034	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PTEN—meningioma	0.000309	0.000335	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—AKT1—meningioma	0.000308	0.000334	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—ERBB2—meningioma	0.000307	0.000333	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—ERBB2—meningioma	0.000307	0.000333	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—ERBB2—meningioma	0.000307	0.000333	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—AKT1—meningioma	0.000306	0.000333	CbGpPWpGaD
Carfilzomib—PSMB10—Gene Expression—AKT1—meningioma	0.000306	0.000332	CbGpPWpGaD
Carfilzomib—PSMB9—Gene Expression—AKT1—meningioma	0.000305	0.000331	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—ERBB2—meningioma	0.000303	0.000329	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.000285	0.00031	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—AKT1—meningioma	0.000284	0.000309	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—AKT1—meningioma	0.000283	0.000307	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PTEN—meningioma	0.000262	0.000284	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PTEN—meningioma	0.000262	0.000284	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PTEN—meningioma	0.000262	0.000284	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PTEN—meningioma	0.000258	0.00028	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—AKT1—meningioma	0.000238	0.000259	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—AKT1—meningioma	0.000237	0.000257	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TP53—meningioma	0.000236	0.000256	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TP53—meningioma	0.000235	0.000255	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—AKT1—meningioma	0.000233	0.000253	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—AKT1—meningioma	0.000233	0.000253	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—AKT1—meningioma	0.000233	0.000253	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—AKT1—meningioma	0.000232	0.000252	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—AKT1—meningioma	0.000232	0.000252	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—AKT1—meningioma	0.000232	0.000252	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—AKT1—meningioma	0.00023	0.00025	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—AKT1—meningioma	0.000229	0.000248	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—AKT1—meningioma	0.000215	0.000234	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—AKT1—meningioma	0.000215	0.000234	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—AKT1—meningioma	0.000215	0.000234	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—AKT1—meningioma	0.000212	0.000231	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—AKT1—meningioma	0.000199	0.000216	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—AKT1—meningioma	0.000198	0.000215	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—AKT1—meningioma	0.00018	0.000196	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—AKT1—meningioma	0.00018	0.000196	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—AKT1—meningioma	0.00018	0.000196	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TP53—meningioma	0.000179	0.000194	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TP53—meningioma	0.000179	0.000194	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TP53—meningioma	0.000179	0.000194	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—AKT1—meningioma	0.000178	0.000193	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TP53—meningioma	0.000176	0.000191	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—AKT1—meningioma	0.000151	0.000164	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—AKT1—meningioma	0.000151	0.000164	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—AKT1—meningioma	0.000151	0.000164	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—AKT1—meningioma	0.000149	0.000162	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PTEN—meningioma	9.21e-05	0.0001	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—AKT1—meningioma	5.31e-05	5.76e-05	CbGpPWpGaD
